The combination of an experimental BioAge Labs drug with the approved Eli Lilly obesity medication Zepbound has hit a major setback: a safety signal observed in some clinical trial participants that ...

BioAge Labs has garnered the support of Eli Lilly to run a trial combining a muscle regeneration therapy with the Big Pharma’s tirzepatide for healthier weight loss. While no financial details were ...

Interest in metabolic medicines is riding high, led by the popular class of weight management drugs known as GLP-1 agonists. BioAge Labs aims to help those medications work better with a lead drug ...